AstraZeneca to withdraw Imfinzi U.S. indication for advanced bladder cancer


FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo

(Reuters) - AstraZeneca will voluntarily withdraw the use of its cancer drug Imfinzi to treat advanced bladder cancer in the United States after it failed to meet post-approval requirements, the Anglo-Swedish drugmaker said on Monday.

Imfinzi, mainly a lung cancer treatment, was granted accelerated approval for the bladder cancer indication in 2017, and the withdrawal does not impact markets outside the United States, the company said.

The treatment failed the main goal of a late-state trial last year and the decision was based in consultation with U.S. authorities, the company said.

"While the withdrawal in previously treated metastatic bladder cancer is disappointing, we respect the principles FDA set out when the accelerated approval pathway was founded," Dave Fredrickson, executive vice president of the company's oncology business division, said in a statement.

Imfinzi belongs to the immunotherapy class of treatments that boost the body's own defences to fight cancer by using antibodies that block or bind to foreign substances in the body.

AstraZeneca also said other U.S. indications for the drug, which brought in $2.04 billion in global revenue last year, were not affected by the withdrawal, adding that it was notifying healthcare providers of the update.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Sriraj Kalluvila)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In World

Hungary's new LGBT law contradicts EU values, Germany says
South Africans battle to bridge digital divide in Covid-19 vaccination race
Vaccinated Brits could be back on Europe's beaches soon - minister
Myanmar army clashes with anti-junta militia in Mandalay city
Rights group urges UN pressure campaign against Nicaragua president
EU data watchdogs want ban on AI facial recognition
Guatemalan "high risk court" judges say they are being persecuted, harassed
Migrant children report overcrowding, spoiled food, depression in U.S. shelters
North Korea ridicules U.S. hopes for talks as allies rethink approach
Peruvian judge in Keiko Fujimori corruption case rejects call to return her to prison

Stories You'll Enjoy


Vouchers